Properties (44)
Predicate | Object |
---|---|
gptkbp:instanceOf |
stem cells
|
gptkbp:area |
controversial research practices
|
gptkbp:built |
human embryos
|
gptkbp:canBe |
laboratory conditions
|
gptkbp:canLeadTo |
muscle cells
immune cells blood cells differentiate into neurons differentiate into cardiomyocytes differentiate into pancreatic cells |
gptkbp:exhibits |
pluripotency
|
gptkbp:geneticDiversity |
study gene function
|
gptkbp:hasDeveloped |
tissue engineering solutions
|
gptkbp:hasFestival |
blastocysts
|
gptkbp:hasPerformance |
treating diseases
|
gptkbp:hasRelatedPatent |
drug testing
|
https://www.w3.org/2000/01/rdf-schema#label |
human embryonic stem cells
|
gptkbp:isAccessibleBy |
adult stem cells
|
gptkbp:isConsidered |
a source of personalized medicine
|
gptkbp:isFacilitatedBy |
pharmaceutical compounds
|
gptkbp:isPartOf |
clinical trials
biomedical research stem cell research |
gptkbp:isStudiedIn |
treatment of diabetes
treatment of Parkinson's disease treatment of heart disease treatment of spinal cord injuries treatment_of_ALS |
gptkbp:isSubjectTo |
regulatory oversight
|
gptkbp:isUsedBy |
cellular aging
|
gptkbp:isUsedFor |
embryonic development
cell signaling pathways developmental biology biobanks organoids organs for transplantation patient-specific cell lines |
gptkbp:isUsedIn |
cell therapy
|
gptkbp:isUtilizedFor |
genetic disorders
cancer biology |
gptkbp:mayHave |
teratomas in vivo
|
gptkbp:raisesAwarenessAbout |
embryo destruction
|
gptkbp:suitableFor |
differentiating into any cell type
|
gptkbp:usedIn |
regenerative medicine
|